Level C· Early human research exploring benefitsCohort StudyPubMed

IMPACT OF ADJUVANT FAT GRAFTING ON IMPROVED UPTAKE AND HEALING OF SPLIT THICKNESS SKIN GRAFT AT TERTIARY CARE HOSPITAL.

Bhutto SA., Ali Khan FA., Sami W., Noor M., Farrrukh R., Khan S.

Cohort Study on Chronic Wound, published in J Ayub Med Coll Abbottabad (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
J Ayub Med Coll Abbottabad (2024)
Country
Pakistan
Reported sample size
—
Source database
PubMed
PMID
39609988
DOI
10.55519/JAMC-02-12934

Abstract (original English)

Since the 1980s, autologous fat grafting has been one of the most widely used methods in plastic surgery to treat volume and contour problems. There are many advantages of autologous fat, i.e., it is cheap, biocompatible, and readily available autologous tissue in large quantities, minimal morbidity. Objective was to compare the outcomes of fat grafting combined with STSGs and STSGs alone in patients with chronic non-healing wounds presenting at a tertiary care hospital. It was a prospective cohort study carried out at the Department of plastic surgery, Civil hospital Karachi, Pakistan from 11th April to 12th October 2023. Patients aged 18-60 years with chronic non-healing wounds due to burn, trauma, or infection lasting at least six weeks were included. Group A received fat grafting followed by STSGs, while Group B received STSGs alone. Follow-up for both groups continued for 4-5 weeks, focusing on graft uptake and healing, with successful graft take defined as wound healing upon clinical examination. Data was analyzed by SPSS version 25. Overall, the mean age of the patients was 36.47±8.57 years. In Group A, the median width was 8.00 cm, and in Group B, it was 7.00 cm, this difference was statistically significant (p=0.005). The proportion of healing in group A was significantly higher as compared to group B (66.7% vs 30%, (p=0.001). The odds of wound healing were 0.21 times

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansAdultFemaleSkin TransplantationWound HealingMaleProspective StudiesAdipose TissueTertiary Care CentersMiddle Aged

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research